AkzoNobel Share Price Euronext Amsterdam
Equities
NL0000009132
Commodity Chemicals
Sales 2024 * | 10.8B 11.75B 926B | Sales 2025 * | 11.12B 12.11B 954B | Capitalization | 11.16B 12.15B 957B |
---|---|---|---|---|---|
Net income 2024 * | 648M 706M 55.61B | Net income 2025 * | 744M 810M 63.85B | EV / Sales 2024 * | 1.36 x |
Net Debt 2024 * | 3.55B 3.87B 305B | Net Debt 2025 * | 3.25B 3.54B 279B | EV / Sales 2025 * | 1.3 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
14.7
x | Employees | - |
Yield 2024 * |
3.07% | Yield 2025 * |
3.2% | Free-Float | 98.46% |
Latest transcript on AkzoNobel
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 31/10/22 | |
Maarten de Vries
DFI | Director of Finance/CFO | 62 | 31/12/17 |
Kenny Chae
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Byron Grote
BRD | Director/Board Member | 76 | 28/04/14 |
Ben Noteboom
CHM | Chairman | 65 | 30/06/23 |
Dick M. Sluimers
BRD | Director/Board Member | 71 | 21/04/15 |
1st Jan change | Capi. | |
---|---|---|
+1.43% | 79.66B | |
-17.30% | 32.92B | |
-9.70% | 31.86B | |
-1.58% | 16.83B | |
+1.56% | 14.63B | |
+4.71% | 8.06B | |
-19.74% | 6.91B | |
-8.47% | 2.98B | |
-14.09% | 2.71B |